Journal
DRUG DISCOVERY TODAY
Volume 14, Issue 1-2, Pages 25-30Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2008.11.001
Keywords
-
Categories
Funding
- [NKBRP2005CB522605]
- [SKLZZ200810]
- [NFSC30870966]
- [FANEDD200777]
- [IRT0712]
- [CSTC2008BB5023]
Ask authors/readers for more resources
beta 2-Microglobulin, a MHC class I subunit, is found to act similarly to a prototypical oncogenic factor capable of stimulating growth and progression of various cancers and plays a key regulatory role in stimulating cancer bone metastasis. Free beta 2M in serum or urine has been regarded as an independent biomarker in several cancers. Specific antibodies to beta 2M have remarkable tumoricidal activity for both solid tumors and blood malignancies and are shown to be selective to tumor cells, but caused no toxicity in normal cells. These surprising data strongly suggest that beta 2M is a promising new therapeutic target for human cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available